Paper published in a journal (Scientific congresses and symposiums)
Cost-effectiveness analysis of pharmaceutical-grade chondroitin sulfate in the treatment of knee osteoarthritis: a post hoc assessment derived from individual patient data from a randomised clinical triall
Bruyère, Olivier; Reginster, Jean-Yves
2024In Aging Clinical and Experimental Research
Peer Reviewed verified by ORBi
 

Files


Full Text
P1009 - Cost-effectiveness analysis ... Abstract Book p604.pdf
Publisher postprint (71.26 kB) Creative Commons License - Attribution
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Public health, health care sciences & services
Author, co-author :
Bruyère, Olivier  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique
Language :
English
Title :
Cost-effectiveness analysis of pharmaceutical-grade chondroitin sulfate in the treatment of knee osteoarthritis: a post hoc assessment derived from individual patient data from a randomised clinical triall
Publication date :
2024
Event name :
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Event organizer :
WCO-IOF-ESCEO
Event place :
London, United Kingdom
Event date :
11 avril -14 avril 2024
Audience :
International
Journal title :
Aging Clinical and Experimental Research
ISSN :
1594-0667
eISSN :
1720-8319
Publisher :
Springer, Germany
Special issue title :
and Abstract Book of the Congress
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 16 May 2024

Statistics


Number of views
19 (5 by ULiège)
Number of downloads
33 (4 by ULiège)

Bibliography


Similar publications



Contact ORBi